As the Trump Administration and States Push Health Data Sharing, Familiar Challenges Surface
The Northeast Valley Health Corp. in Los Angeles County could be a poster child for…
As the Trump Administration and States Push Health Data Sharing, Familiar Challenges Surface
The Northeast Valley Health Corp. in Los Angeles County could be a poster child for the benefits of sharing health data electronically. Through a data network connecting its records system with other providers, the health center receives not just X-ray and lab results but real-time alerts when hospitals on the network admit or discharge its…
New Bereavement Cost Calculator shows that grief is expensive
by EMMA PAYNE Grief is expensive. In addition to the significant human impacts, research shows that bereavement leads to a 20%-30% increase in health care utilization. Grief is also common. While we may not like to talk about it, 37% of Americans are grieving a recent death. The U.S. averaged 3.26 million deaths per year…
‘Sick to My Stomach’: Trump Distorts Facts on Autism, Tylenol, and Vaccines, Scientists Say
Ann Bauer, a researcher who studies Tylenol and autism, felt queasy with anxiety in the weeks leading up to the White House’s much-anticipated autism announcement. In August, Bauer and her colleagues published an analysis of 46 previous studies on Tylenol, autism, and attention-deficit/hyperactivity disorder. Many found no link between the drug and the conditions, while…
AI Hallucinations: What Are They and Are They Always Bad?
AI hallucinations may not always be bad, according to a panel of experts at the MedCity INVEST Digital Health conference. Instead, they may let people know when there are gaps in the data. The post AI Hallucinations: What Are They and Are They Always Bad? appeared first on MedCity News.
Pfizer’s $4.9B Metsera Acquisition Positions It to Become Major Player in Obesity Drugs & More
Pfizer is acquiring Metsera and its pipeline of obesity medications that could offer dosing and tolerability advantages for patients as well as a manufacturing edge for the pharma giant. Key data Phase 2 readouts for Metsera’s lead GLP-1 drug candidate are expected in 2026. The post Pfizer’s $4.9B Metsera Acquisition Positions It to Become Major…
Pharmacogenomics Can Help Buffer Female Cardiac Patients From Impacts Of Funding Cuts
Pharmacogenomics offers an opportunity to help shield female cardiology patients from some of the negative impacts by helping to streamline the process from diagnosis to finding a successful treatment for that patient. The post Pharmacogenomics Can Help Buffer Female Cardiac Patients From Impacts Of Funding Cuts appeared first on MedCity News.
5 Key Facts About Medicaid Coverage for People With Intellectual and Developmental Disabilities (I/DD)
Among the estimated 8 million people with intellectual and developmental disabilities (I/DD), over three million have Medicaid coverage.
Treating Uncertainty: How Successful Pharma Leaders Can Protect Employee Wellbeing and the Bottom Line
With employee anxiety at an all-time high, reducing fear and stress is increasingly important to organizational performance. While leaders cannot control external events, they can help mitigate their impacts on their organizations and people. The post Treating Uncertainty: How Successful Pharma Leaders Can Protect Employee Wellbeing and the Bottom Line appeared first on MedCity News.
The Impact of H.R. 1 on Two Medicaid Eligibility Rules
This issue brief describes the impact of H.R.1’s 10-year delay in implementing provisions in two Medicaid eligibility rules that would have reduced red tape. The delayed rules are projected to decrease federal spending and future Medicaid and CHIP enrollment and increase coverage loss.
States Are Cutting Medicaid Provider Payments Long Before Trump Cuts Hit
Every day for nearly 18 years, Alessandra Fabrello has been a medical caregiver for her son, on top of being his mom. “It is almost impossible to explain what it takes to keep a child alive who should be dead,” said Fabrello, whose son, Ysadore Maklakoff, experienced a rare brain condition called acute necrotizing encephalopathy…
